Medome is a first of its kind patented Advanced Health Intelligence ™ application for consumers based on its AI-First Primary Care model™ developed by physiciansMedome is a first of its kind patented Advanced Health Intelligence ™ application for consumers based on its AI-First Primary Care model™ developed by physicians

MEDOME RELEASES SOLUTION TO END MISDIAGNOSIS IN PRIMARY CARE; WILL SAVE 100s OF THOUSANDS OF LIVES ANNUALLY

2026/02/05 22:02
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

Medome is a first of its kind patented Advanced Health Intelligence ™ application for consumers based on its AI-First Primary Care model™ developed by physicians as a personal health adviser, guide, companion, and checker that helps consumers and caregivers show up to medical appointments prepared, informed, and ready to advocate for themselves or others, turning confusing healthcare experiences into ones they can actually navigate. Given that unprepared patients incur hundreds to thousands in preventable spending, which can lead to devastating personal financial consequences, Medome tackles a major problem that affects nearly everyone but has until now gotten scant attention. Our health system demands too much from doctors, which annually leads to 800,000 deadly, life-altering errors.

NEW YORK, Feb. 5, 2026 /PRNewswire/ — After losing his brother and then a close friend to diagnostic errors, then surviving one himself, Dr. Steven Charlap set out to prevent others from experiencing the same. His brother was a cardiologist who trusted the system that he’d been part of for decades. It missed his fatal disease. He died. A fellow physician suffered the same fate. Then Dr. Steven Charlap, the cardiologist’s younger brother and a 35-year year physician himself at the time, faced his own misdiagnosis, and barely survived. Three doctors. Three misdiagnoses. Two dead.

Your doctor is human. That’s why there’s Medome.ai is always at your service.

According to Johns Hopkins, diagnostic errors kill nearly 400,000 Americans and permanently disable over 400,000 more every year. Over a million more just suffer. That’s over 2,000 people per day. The healthcare system has done nothing about it. Neither has the government. Neither has the private sector. Dr. Charlap decided to change that. He spent five years at Stanford and Harvard developing Medome, the first tool designed to prevent misdiagnosis before it happens.

“Your doctor went into medicine to help people, but they are fighting a system that gives them 15 minutes and 2,300 patients. They are responsible for your symptoms; you are responsible for your story. Because your doctor is human, they might miss the pattern buried in a file from five years ago. Because Medome is not, we won’t. Doctors are human. That’s why there’s Medome,” said Dr. Charlap

WHAT MEDOME DOES

Before appointments: Consolidates and curates your complete medical history. Runs advanced risk and symptom assessments. Prepares questions for your doctor and a clinical note with possible diagnoses, proven to improve accuracy.

During appointments: Records the encounter. Delivers an on-the-spot second opinion. Flags discrepancies.

After appointments: Monitors for warning signs and signals. Ensures nothing gets missed.

Medome also integrates with wearables and any health data, including from LLMs, and through HealthSigns, its proprietary system that personalizes guidance based on your health archetype.

PROOF IT WORKS

Validated by 20,000+ users. Supported by Stanford, Harvard, NIH, and NHS. Already saving lives by catching what doctors missed.

“Doctors are human. They’re overworked. They have fifteen minutes per patient,” said Dr. Charlap. “They need help. Patients need protection. That’s Medome.” www.medome.ai“

Medome is available now at www.medome.ai

MEDIA CONTACT: Steven Charlap, MD | [email protected] | 617-319-6434

ABOUT MEDOME: New York-based health technology company founded by Dr. Steven Charlap and Paul Battle. Built-on five years of research at Stanford and Harvard. Medome is the first platform designed to prevent misdiagnosis by preparing patients and doctors before appointments, providing real-time second opinions, and safeguarding against mistakes. Medome has already been validated by 20,000+ users and supported by Stanford, Harvard, NIH, and NHS.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/medome-releases-solution-to-end-misdiagnosis-in-primary-care-will-save-100s-of-thousands-of-lives-annually-302679821.html

SOURCE Medome

Market Opportunity
READY Logo
READY Price(READY)
$0.020258
$0.020258$0.020258
-0.43%
USD
READY (READY) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor’s Strategy Buys $2,010,000 Worth of Bitcoin in One of the Firm’s Largest Acquisitions Ever

Michael Saylor’s Strategy Buys $2,010,000 Worth of Bitcoin in One of the Firm’s Largest Acquisitions Ever

The post Michael Saylor’s Strategy Buys $2,010,000 Worth of Bitcoin in One of the Firm’s Largest Acquisitions Ever appeared on BitcoinEthereumNews.com. Michael
Share
BitcoinEthereumNews2026/05/19 15:17
One Of Frank Sinatra’s Most Famous Albums Is Back In The Spotlight

One Of Frank Sinatra’s Most Famous Albums Is Back In The Spotlight

The post One Of Frank Sinatra’s Most Famous Albums Is Back In The Spotlight appeared on BitcoinEthereumNews.com. Frank Sinatra’s The World We Knew returns to the Jazz Albums and Traditional Jazz Albums charts, showing continued demand for his timeless music. Frank Sinatra performs on his TV special Frank Sinatra: A Man and his Music Bettmann Archive These days on the Billboard charts, Frank Sinatra’s music can always be found on the jazz-specific rankings. While the art he created when he was still working was pop at the time, and later classified as traditional pop, there is no such list for the latter format in America, and so his throwback projects and cuts appear on jazz lists instead. It’s on those charts where Sinatra rebounds this week, and one of his popular projects returns not to one, but two tallies at the same time, helping him increase the total amount of real estate he owns at the moment. Frank Sinatra’s The World We Knew Returns Sinatra’s The World We Knew is a top performer again, if only on the jazz lists. That set rebounds to No. 15 on the Traditional Jazz Albums chart and comes in at No. 20 on the all-encompassing Jazz Albums ranking after not appearing on either roster just last frame. The World We Knew’s All-Time Highs The World We Knew returns close to its all-time peak on both of those rosters. Sinatra’s classic has peaked at No. 11 on the Traditional Jazz Albums chart, just missing out on becoming another top 10 for the crooner. The set climbed all the way to No. 15 on the Jazz Albums tally and has now spent just under two months on the rosters. Frank Sinatra’s Album With Classic Hits Sinatra released The World We Knew in the summer of 1967. The title track, which on the album is actually known as “The World We Knew (Over and…
Share
BitcoinEthereumNews2025/09/18 00:02
Moody’s Assigns First-Ever Rating to Bitcoin-Backed Municipal Bond in Historic Crypto Finance Move

Moody’s Assigns First-Ever Rating to Bitcoin-Backed Municipal Bond in Historic Crypto Finance Move

TLDR: Moody’s assigned a provisional Ba2 rating to a $100M Bitcoin-backed New Hampshire municipal bond, a market first. The bond requires 160% Bitcoin overcollateralization
Share
Blockonomi2026/04/02 18:15

No Chart Skills? Still Profit

No Chart Skills? Still ProfitNo Chart Skills? Still Profit

Copy top traders in 3s with auto trading!